In fact, recently, PTGS2 overexpression in tumor tissues of CRC patients (immunohistochemical and qPCR method) was closely associated with clinico-pathological data demonstrating a more pronounced expression in males vs. females [53]. This evidence concerns the gene PTGS2 and colorectal carcinoma.